HIV Continuum of Care for Youth in the United States

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: Beneficial HIV treatment outcomes require success at multiple steps along the HIV Continuum of Care. Youth living with HIV are a key population, and sites in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) are known for modeling optimum HIV adolescent care.

METHODS: A longitudinal cohort study conducted at 14 network sites across the United States assessed how the later steps of the Continuum of Care were achieved among the youth: engagement, treatment, and viral load (VL) suppression. Youth aged 13-24 who were behaviorally infected with HIV and linked to care at an ATN-affiliated site were eligible to participate.

RESULTS: A total of 467 youth were enrolled and had 1 year of available data. Most were aged 22-24 (57%), male (79%), and black/non-Hispanic (71%). Most used alcohol (81%) and marijuana (61%) in the 3 months before enrollment, and 40% had a history of incarceration. Among this cohort of youth, 86% met criteria for care engagement; among these, 98% were prescribed antiretroviral therapy and 89% achieved VL suppression. Sustained VL suppression at all measured time points was found among 59% with initial suppression. Site characteristics were notable for the prevalence of adherence counseling (100%), case management (100%), clinic-based mental health (93%), and substance use (64%) treatment.

CONCLUSIONS: Youth living with HIV in the United States can be successfully treated at health care sites with experience, excellence, and important resources and services. Sustained VL suppression may be an important step to add to the Continuum of Care for youth.

Original languageEnglish (US)
Pages (from-to)110-117
Number of pages8
JournalJournal of acquired immune deficiency syndromes (1999)
Volume77
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Continuity of Patient Care
HIV
Viral Load
Adolescent Medicine
Case Management
Cannabis
Longitudinal Studies
Counseling
Mental Health
Acquired Immunodeficiency Syndrome
Cohort Studies
Therapeutics
Alcohols
Delivery of Health Care

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

HIV Continuum of Care for Youth in the United States. / Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN).

In: Journal of acquired immune deficiency syndromes (1999), Vol. 77, No. 1, 01.01.2018, p. 110-117.

Research output: Contribution to journalArticle

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 2018, 'HIV Continuum of Care for Youth in the United States', Journal of acquired immune deficiency syndromes (1999), vol. 77, no. 1, pp. 110-117. https://doi.org/10.1097/QAI.0000000000001563
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). / HIV Continuum of Care for Youth in the United States. In: Journal of acquired immune deficiency syndromes (1999). 2018 ; Vol. 77, No. 1. pp. 110-117.
@article{1723f156c36541fc86002bc68d32390f,
title = "HIV Continuum of Care for Youth in the United States",
abstract = "BACKGROUND: Beneficial HIV treatment outcomes require success at multiple steps along the HIV Continuum of Care. Youth living with HIV are a key population, and sites in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) are known for modeling optimum HIV adolescent care.METHODS: A longitudinal cohort study conducted at 14 network sites across the United States assessed how the later steps of the Continuum of Care were achieved among the youth: engagement, treatment, and viral load (VL) suppression. Youth aged 13-24 who were behaviorally infected with HIV and linked to care at an ATN-affiliated site were eligible to participate.RESULTS: A total of 467 youth were enrolled and had 1 year of available data. Most were aged 22-24 (57{\%}), male (79{\%}), and black/non-Hispanic (71{\%}). Most used alcohol (81{\%}) and marijuana (61{\%}) in the 3 months before enrollment, and 40{\%} had a history of incarceration. Among this cohort of youth, 86{\%} met criteria for care engagement; among these, 98{\%} were prescribed antiretroviral therapy and 89{\%} achieved VL suppression. Sustained VL suppression at all measured time points was found among 59{\%} with initial suppression. Site characteristics were notable for the prevalence of adherence counseling (100{\%}), case management (100{\%}), clinic-based mental health (93{\%}), and substance use (64{\%}) treatment.CONCLUSIONS: Youth living with HIV in the United States can be successfully treated at health care sites with experience, excellence, and important resources and services. Sustained VL suppression may be an important step to add to the Continuum of Care for youth.",
author = "{Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)} and Lally, {Michelle A.} and {van den Berg}, {Jacob J.} and Westfall, {Andrew O.} and Rudy, {Bret J.} and Hosek, {Sybil G.} and J. Fortenberry and Dina Monte and Tanney, {Mary R.} and McFarland, {Elizabeth J.} and Jiahong Xu and Kapogiannis, {Bill G.} and Wilson, {Craig M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/QAI.0000000000001563",
language = "English (US)",
volume = "77",
pages = "110--117",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - HIV Continuum of Care for Youth in the United States

AU - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)

AU - Lally, Michelle A.

AU - van den Berg, Jacob J.

AU - Westfall, Andrew O.

AU - Rudy, Bret J.

AU - Hosek, Sybil G.

AU - Fortenberry, J.

AU - Monte, Dina

AU - Tanney, Mary R.

AU - McFarland, Elizabeth J.

AU - Xu, Jiahong

AU - Kapogiannis, Bill G.

AU - Wilson, Craig M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - BACKGROUND: Beneficial HIV treatment outcomes require success at multiple steps along the HIV Continuum of Care. Youth living with HIV are a key population, and sites in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) are known for modeling optimum HIV adolescent care.METHODS: A longitudinal cohort study conducted at 14 network sites across the United States assessed how the later steps of the Continuum of Care were achieved among the youth: engagement, treatment, and viral load (VL) suppression. Youth aged 13-24 who were behaviorally infected with HIV and linked to care at an ATN-affiliated site were eligible to participate.RESULTS: A total of 467 youth were enrolled and had 1 year of available data. Most were aged 22-24 (57%), male (79%), and black/non-Hispanic (71%). Most used alcohol (81%) and marijuana (61%) in the 3 months before enrollment, and 40% had a history of incarceration. Among this cohort of youth, 86% met criteria for care engagement; among these, 98% were prescribed antiretroviral therapy and 89% achieved VL suppression. Sustained VL suppression at all measured time points was found among 59% with initial suppression. Site characteristics were notable for the prevalence of adherence counseling (100%), case management (100%), clinic-based mental health (93%), and substance use (64%) treatment.CONCLUSIONS: Youth living with HIV in the United States can be successfully treated at health care sites with experience, excellence, and important resources and services. Sustained VL suppression may be an important step to add to the Continuum of Care for youth.

AB - BACKGROUND: Beneficial HIV treatment outcomes require success at multiple steps along the HIV Continuum of Care. Youth living with HIV are a key population, and sites in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) are known for modeling optimum HIV adolescent care.METHODS: A longitudinal cohort study conducted at 14 network sites across the United States assessed how the later steps of the Continuum of Care were achieved among the youth: engagement, treatment, and viral load (VL) suppression. Youth aged 13-24 who were behaviorally infected with HIV and linked to care at an ATN-affiliated site were eligible to participate.RESULTS: A total of 467 youth were enrolled and had 1 year of available data. Most were aged 22-24 (57%), male (79%), and black/non-Hispanic (71%). Most used alcohol (81%) and marijuana (61%) in the 3 months before enrollment, and 40% had a history of incarceration. Among this cohort of youth, 86% met criteria for care engagement; among these, 98% were prescribed antiretroviral therapy and 89% achieved VL suppression. Sustained VL suppression at all measured time points was found among 59% with initial suppression. Site characteristics were notable for the prevalence of adherence counseling (100%), case management (100%), clinic-based mental health (93%), and substance use (64%) treatment.CONCLUSIONS: Youth living with HIV in the United States can be successfully treated at health care sites with experience, excellence, and important resources and services. Sustained VL suppression may be an important step to add to the Continuum of Care for youth.

UR - http://www.scopus.com/inward/record.url?scp=85038360032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038360032&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000001563

DO - 10.1097/QAI.0000000000001563

M3 - Article

VL - 77

SP - 110

EP - 117

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -